The full story: Samir El-Alami and doctorly

One of the reasons why I first started researching early-stage entrepreneurs was because I relished the chance of seeing the future being made. Sometimes these changes come rapidly, with startups chasing competitors, and others, they’re the product of careful germination and patient product research. A perfect example of this is doctorly, a yet-to-launch health tech […]

White Fund tech.eu

White Fund, new early-stage fund for Belgian medtech, announces first close of €20 million

Two Belgian investment managers from Noshaq have launched White Fund, a new €20 million private equity fund dedicated to early-stage medtech startups, particularly Belgian companies developing medical devices.  The fund aims to raise an additional €10 million over the next few months. Joanna Tyrekidis and Benoit Fellin announced the medtech fund has reached its first […]

FundamentalVR tech.eu

FundamentalVR raises £4.3 million to develop flight simulator for surgeons, backed by Mayo Clinic

FundamentalVR, the award-winning medical tech company, has announced a £4.3 million Series A led by Downing Ventures, with support from Tern, Epic Private Equity, and Brighteyes Ventures. The round is also joined by leading medical institutions, including Mayo Clinic, one of America’s leading medical centres, and Sana Kliniken, the third largest hospital organisation in Germany. […]

Aqemia tech.eu

Aqemia raises €1 million pre-seed round to disrupt drug discovery market

Aqemia, a Parisian deep tech startup, has raised €1 million pre-seed round from Elaia to develop its molecule matching technology. The company aims to transform pharmaceutical research and disrupt the $60 billion drug discovery market. Aqemia’s core software, developed from academic research at École normale supérieure (PSL), can predict the effectiveness of a pharmaceutical drug. […]

Healx tech.eu

Healx gets $56 million Series B to find treatments for the world’s rare diseases

Cambridge-based Healx, an AI-powered biotech company researching treatments for rare diseases, has raised a $56 million Series B led by Atomico, joined by Intel Capital, Global Brain and btov Partners. The investment enables the company to launch its global Rare Treatment Accelerator programme, as well as pursue ongoing research. Healx is innovating on the traditional […]